Queen mandibular pheromone (QMP) is produced by honey bee queens and used to regulate the behavior and physiology of their nestmates [1] . QMP has recently been shown to block aversive learning in young worker bees, an effect that can be mimicked by treating bees with one of QMP's key components, homovanillyl alcohol (HVA) [2] . Although the mechanisms underlying this blockade remain unclear, HVA has been found to lower brain dopamine levels and to alter intracellular levels of cAMP in brain centers involved in learning and memory [3] . These findings led to the hypothesis that HVA targets dopamine pathways in the brain [3] , which are known to play a critical role in the formation of aversive olfactory memories [4] [5] [6] [7] [8] . Here, we investigate the possibility that HVA interacts directly with dopamine receptors in the bee. We show that HVA selectively activates the D2-like dopamine receptor AmDOP3 but has neither agonist nor antagonist activity on the D1-like receptors AmDOP1 or AmDOP2 nor agonist activity on the octopamine receptor AmOA1. These results suggest a direct molecular mechanism by which queen pheromone can modulate dopamine signaling pathways. They also implicate the dopamine receptor AmDOP3 in HVA-induced blockade of aversive learning in young worker bees.
Summary
Queen mandibular pheromone (QMP) is produced by honey bee queens and used to regulate the behavior and physiology of their nestmates [1] . QMP has recently been shown to block aversive learning in young worker bees, an effect that can be mimicked by treating bees with one of QMP's key components, homovanillyl alcohol (HVA) [2] . Although the mechanisms underlying this blockade remain unclear, HVA has been found to lower brain dopamine levels and to alter intracellular levels of cAMP in brain centers involved in learning and memory [3] . These findings led to the hypothesis that HVA targets dopamine pathways in the brain [3] , which are known to play a critical role in the formation of aversive olfactory memories [4] [5] [6] [7] [8] . Here, we investigate the possibility that HVA interacts directly with dopamine receptors in the bee. We show that HVA selectively activates the D2-like dopamine receptor AmDOP3 but has neither agonist nor antagonist activity on the D1-like receptors AmDOP1 or AmDOP2 nor agonist activity on the octopamine receptor AmOA1. These results suggest a direct molecular mechanism by which queen pheromone can modulate dopamine signaling pathways. They also implicate the dopamine receptor AmDOP3 in HVA-induced blockade of aversive learning in young worker bees.
Results and Discussion
HVA Is Not an AmDOP1 or AmDOP2 Receptor Agonist AmDOP1 and AmDOP2 receptors in honey bees are G proteincoupled receptors that share an important property with the D1-like family of dopamine receptors in vertebrates: activation of these receptors increases levels of the intracellular signaling molecule cAMP [9] [10] [11] . HEK293 cells transfected with an AmDOP1 or AmDOP2 expression construct, together with a cAMP response element (CRE)-luciferase reporter construct, were used to examine whether homovanillyl alcohol (HVA) acts as an AmDOP1 or AmDOP2 receptor agonist. Consistent with earlier studies [9] [10] [11] , we found that dopamine causes a dose-dependent increase in intracellular cAMP levels in cells expressing either AmDOP1 receptors ( Figure 1A , B) or AmDOP2 receptors ( Figure 1B, B) . However, HVA at concentrations of up to 100 mM had no significant effect on cAMP levels in these cells ( Figures 1A and 1B, d) .
To verify these findings, we expressed AmDOP1 and AmDOP2 also in Spodoptera frugiperda (Sf21) cells (an insect cell line) and measured intracellular cAMP levels directly in control (untreated) cells and in cells exposed to either 10 mM dopamine or 10 mM HVA. Whereas dopamine treatment caused robust elevation of cAMP in AmDOP1-and AmDOP2-expressing cells ( Figures 1C and 1D , respectively), HVA had no significant effect on intracellular cAMP levels, nor did it block the effects of dopamine on these cells (Figures 1C and  1D ). These results indicate that HVA has no significant agonist or antagonist activity on the D1-like dopamine receptors AmDOP1 and AmDOP2.
HVA Activates the AmDOP3 Receptor AmDOP3 receptor activation generally leads to a reduction in cAMP levels [12] , a feature characteristic of D2-like dopamine receptors [13] . However, recent evidence suggests that coupling of AmDOP3 with cAMP can vary depending on the cellular environment [14] . To determine whether HVA targets the AmDOP3 receptor and, if so, whether it leads to an increase or decrease in cAMP levels, we expressed AmDOP3 in HEK293 cells and used a CRE-luciferase reporter to monitor changes in intracellular cAMP. Interestingly, not only dopamine but also HVA elicited a dose-dependent inhibitory effect on cAMP levels in AmDOP3-expressing cells (Figure 2A) . HVA was approximately 80-fold less potent than the native ligand (dopamine EC 50 = 0.12 mM; HVA EC 50 = 9.6 mM). To confirm HVA's agonist activity on the AmDOP3 receptor, we expressed AmDOP3 in Sf21 cells also and treated the cells with dopamine or HVA. Both ligands caused a significant reduction in intracellular cAMP levels in AmDOP3-expressing cells ( Figure 2B ).
How Specific Are HVA's Effects? HVA's ability to activate the dopamine receptor AmDOP3 is consistent with studies showing that AmDOP3 receptors are expressed by intrinsic mushroom body neurons [12] and that HVA applied to mushroom bodies of the bee brain mimics the effects of exogenously applied dopamine [3] , but how specific are HVA's effects? Octopamine receptors have also been identified in mushroom bodies of the insect brain [15, 16] , and in bees, as in other insects, octopamine has been strongly implicated in the formation of appetitive memories [4, [17] [18] [19] . To date, only one of several putative octopamine receptors has been cloned and characterized in the bee, AmOA1, activation of which is reported to increase intracellular levels of cAMP [15] . We found that in HEK293 cells expressing AmOA1 receptors, octopamine caused a dosedependent upregulation of cAMP ( Figure 3) . HVA, on the other hand, had no agonist activity in AmOA1-expressing cells. Although we cannot rule out the possibility that HVA interacts with receptors other than AmDOP3, these results add weight to the view that HVA's actions are selective for AmDOP3.
AmDOP3 Receptor Coupling to cAMP
Responses to dopamine and HVA have been shown to vary depending on whether or not bees have been exposed during early adulthood to queen mandibular pheromone (QMP) [3] . In young bees exposed to QMP, HVA or dopamine applied exogenously to calycal regions of the mushroom bodies causes cAMP levels in the tissues to fall, whereas in young bees that have never been exposed to QMP, cAMP levels rise in response to exogenously applied HVA or dopamine [3] . If HVA acts selectively at AmDOP3 receptors, how might these results be explained? Clark and Baro have shown that in arthropods, activation of D2-like dopamine receptors, including AmDOP3, can lead to either an increase or a decrease in intracellular levels of cAMP [14] . Their evidence suggests that not only the G a subunit but also the G bg subunits of the Gi/o proteins that couple to AmDOP3 receptors can contribute to dopamine-induced alterations in intracellular cAMP levels; G a -mediated inhibition of adenylyl cyclase leads to a decrease in cAMP, whereas G bg -mediated stimulation of phospholipase C leads to activation of adenylyl cyclase and an increase in cAMP levels [14] . Similar findings have been reported also for mammalian D2 receptors [20, 21] , and shifts in coupling have been attributed to differences in the intracellular signaling environment [14, 20] . Because QMP has wide-ranging effects on gene expression levels in the brain [22] , it is tempting to speculate that one outcome of this is a change in the intracellular environment that influences the functioning of AmDOP3. Clark and Baro's findings [14] , together with our studies in the bee [3] , would predict that in the brains of young bees exposed to QMP early in adult life, the intracellular environment favors AmDOP3 coupling with cAMP through G a -mediated pathways, whereas in young bees that have never been exposed to this pheromone, AmDOP3 coupling to cAMP via G bg -mediated pathways may be favored. Although this remains speculation, the possibility that QMP influences AmDOP3 receptor coupling to cAMP warrants further attention, because shifts in receptor function could potentially have profound effects not only on brain function but also on the behavior of the bee. The potential for chemical modulators to alter the function of neural circuits and ultimately behavior itself has been demonstrated elegantly in other systems, in particular the stomatogastric nervous system of lobsters and crabs [23] .
The results of our study lend support to the hypothesis that HVA targets dopamine pathways in the bee. We have shown in previous studies that HVA reduces brain dopamine levels and alters intracellular levels of cAMP in brain centers (mushroom bodies) involved in learning and memory [3] . Taken together with evidence showing that intrinsic mushroom body neurons (Kenyon cells) express Amdop3 [12] , HVA's selective effects on AmDOP3 receptor function suggest that this D2-like dopamine receptor is likely to be involved in HVA-induced blockade of aversive learning in young worker bees, a finding consistent with the growing body of evidence that dopamine plays a critical role in aversive memory formation in insects.
Experimental Procedures
Luciferase Reporter Assays Receptor coupling to cAMP was assessed indirectly via a CRE-luciferase reporter [24] . Luciferase assays were performed in HEK293 cells maintained as adherent cultures at 37 C/5% CO 2 in phenol red-free DMEM/F12 medium supplemented with 10% fetal calf serum (Invitrogen). Exponentially growing cells were dispensed at a density of 2 3 10 4 cells per well in 96-well, whitewalled, clear-bottomed tissue culture plates (Greiner Bio-One) and allowed to grow for 24 hr. The cells were cotransfected with a receptor expression construct (see the Supplemental Experimental Procedures available online) together with the pGL4.29[luc2P/CRE/Hygro] reporter construct (Promega) via FuGENE HD reagent (Roche). Transfected cells were maintained for a further 24 hr at 37 C prior to assaying for receptor function. Growth medium was carefully aspirated from the cells and immediately replaced with 100 ml of serum-free DMEM/F12 alone or DMEM/F12 containing HVA, dopamine hydrochloride, or DL-octopamine hydrochloride (Sigma-Aldrich) at the concentrations indicated in the figure legends. For analysis of responses in cells expressing AmDOP3, forskolin (100 nM) was also added to the medium to increase the basal level of cAMP. Addition of forskolin at this concentration does not drive adenylate cyclase activity to saturation, and increases in cAMP levels, if they were to occur, would therefore still be detectable under these conditions. Cells were incubated for 3 hr and then assayed for luciferase enzyme activity with Steady-Glo reagent (Promega). Luminescence signal was detected with a BMG FLUOstar Omega microplate instrument.
Competitive Enzyme Immunoassays for cAMP
Receptor coupling to cAMP was assessed directly via competitive enzyme immunoassays. Assays were performed with Spodoptera frugiperda (Sf21) cells, which were maintained as suspension cultures at 28 C in Sf900II medium (Invitrogen). Exponentially growing cells were dispensed at a density of 2.5 3 10 5 /well in 24-well plates (Greiner Bio-One) and allowed to adhere for 1 hr. Expression plasmid constructs (see Supplemental Experimental Procedures) were transfected into the cells via FuGENE6 reagent (Roche), and the cells were maintained for a further 48 hr prior to assaying for receptor function. Cells transfected with pIB/V5-His-GW/LacZ for . Dopamine (10 mM) increases cAMP levels in AmDOP1-and AmDOP2-expressing cells, whereas HVA (10 mM) has no effect on cAMP levels in these cells, nor does it block the response to 10 mM dopamine. Values are means 6 SEM obtained from three independent experiments. Overall statistical significance was determined by one-way ANOVA followed by Tukey-Kramer tests. Letters above each bar indicate the significance of differences between groups. Groups that share a letter are not significantly different. Measurements of intracellular cAMP were used to assess the effects of dopamine and HVA on Sf21 cells expressing honey bee receptor proteins and on control cells expressing b-Gal protein. Growth medium was removed and replaced with fresh serum-free growth medium containing 100 mM 3-isobutyl-1-methylxanthine (IBMX) alone or with dopamine or HVA. For analysis of responses in Sf21 cells expressing the D2-like receptor AmDOP3, forskolin (10 mM) was added to the medium to increase basal cAMP levels. Cells were exposed for 20 min to dopamine or HVA at the concentrations indicated in the figure legends. Intracellular cAMP levels were measured immediately after treatment via a Biotrak competitive enzyme immunoassay (GE Healthcare).
Data Analysis
One-way ANOVA followed by Tukey-Kramer tests for post hoc analysis was used to compare responses to different treatments in Sf21 cells expressing the same receptor. Equality of variance and normality of data were confirmed via Levene and Shapiro-Wilk tests, respectively. For comparing cAMP levels in Sf21 cells expressing AmDOP3 versus b-Gal, Student's two-tailed t test was used. EC 50 values were calculated from concentration response curves with the sigmoidal dose-response (variable slope) analysis program GraphPad Prism version 5.0b for Macintosh.
All experiments described in this work comply with the laws of New Zealand regulating scientific research.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and can be found with this article online at http://www.cell.com/current-biology/ supplemental/S0960-9822(09)01186-5. 
